About Grifols SA 
Grifols SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1,874 Million
(Quarterly Results - Jun 2026)
Net Profit:
183 Million
Pharmaceuticals & Biotechnology
EUR 6,140 Million ()
12.00
NA
1.14%
1.59
9.74%
1.11






